U.S. Congress invites pharmacy benefit managers to third drug pricing hearing

The U.S. Senate Finance Committee has invited https://www.finance.senate.gov/chairmans-news/grassley-wyden-invite-5-pharmacy-benefit-managers-to-drug-pricing-hearing executives from five pharmacy benefit managers to testify on April 3 on the rising costs of prescription medicines, in Congress's latest effort to question industry officials directly over an issue voters consistently cite as a top concern.